April 15, 2015 | The Israeli stem cell solutions company Accellta announced that it signed an exclusive agreement with the international company Stem Cell Technologies. As part of the agreement, Stem Cell Technologies will market Accellta’s culturing platform that grows stem cells. Accellta was founded at the AMIT Institute of the Technion Israel Institute of Technology.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments